These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3484755)

  • 1. Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf.
    Scott CF; Carrell RW; Glaser CB; Kueppers F; Lewis JH; Colman RW
    J Clin Invest; 1986 Feb; 77(2):631-4. PubMed ID: 3484755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 1-antitrypsin-Pittsburgh: a potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf.
    Scott CF; Carrell RW; Glaser CB; Lewis JH; Colman RW
    Trans Assoc Am Physicians; 1985; 98():344-51. PubMed ID: 3879844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant alpha 1-antitrypsin Pittsburgh (Met 358----Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment.
    Schapira M; Ramus MA; Jallat S; Carvallo D; Courtney M
    J Clin Invest; 1986 Feb; 77(2):635-7. PubMed ID: 3484756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G; Janssen-Claessen T; Rosing J; Griffin JH
    Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor.
    de Agostini A; Lijnen HR; Pixley RA; Colman RW; Schapira M
    J Clin Invest; 1984 Jun; 73(6):1542-9. PubMed ID: 6725552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragment.
    Schapira M; Ramus MA; Waeber B; Brunner HR; Jallat S; Carvallo D; Roitsch C; Courtney M
    J Clin Invest; 1987 Aug; 80(2):582-5. PubMed ID: 3497179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivity of alpha 1-antitrypsin mutants against proteolytic enzymes of the kallikrein-kinin, complement, and fibrinolytic systems.
    Patston PA; Roodi N; Schifferli JA; Bischoff R; Courtney M; Schapira M
    J Biol Chem; 1990 Jun; 265(18):10786-91. PubMed ID: 2191958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of inhibition of human plasma kallikrein by a site-specific modified inhibitor Arg15-aprotinin: evaluation using a microplate system and comparison with other proteases.
    Scott CF; Wenzel HR; Tschesche HR; Colman RW
    Blood; 1987 May; 69(5):1431-6. PubMed ID: 2436687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor.
    Meijers JC; Kanters DH; Vlooswijk RA; van Erp HE; Hessing M; Bouma BN
    Biochemistry; 1988 Jun; 27(12):4231-7. PubMed ID: 2844223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of heparin on the inactivation rate of human activated factor XII by antithrombin III.
    Pixley RA; Schapira M; Colman RW
    Blood; 1985 Jul; 66(1):198-203. PubMed ID: 3873967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 1-antitrypsin Pittsburgh (Met358-->Arg) inhibits the contact pathway of intrinsic coagulation and alters the release of human neutrophil elastase during simulated extracorporeal circulation.
    Wachtfogel YT; Bischoff R; Bauer R; Hack CE; Nuijens JH; Kucich U; Niewiarowski S; Edmunds LH; Colman RW
    Thromb Haemost; 1994 Dec; 72(6):843-7. PubMed ID: 7740452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin.
    Heck LW; Kaplan AP
    J Exp Med; 1974 Dec; 140(6):1615-30. PubMed ID: 4547783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa.
    Wuillemin WA; Eldering E; Citarella F; de Ruig CP; ten Cate H; Hack CE
    J Biol Chem; 1996 May; 271(22):12913-8. PubMed ID: 8662679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin.
    Holmer E; Kurachi K; Söderström G
    Biochem J; 1981 Feb; 193(2):395-400. PubMed ID: 6914196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant alpha 1-antitrypsin Pittsburgh attenuates experimental gram-negative septicemia.
    Colman RW; Flores DN; De La Cadena RA; Scott CF; Cousens L; Barr PJ; Hoffman IB; Kueppers F; Fisher D; Idell S
    Am J Pathol; 1988 Feb; 130(2):418-26. PubMed ID: 3257651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major inhibitors of the contact phase coagulation factors.
    Schapira M
    Semin Thromb Hemost; 1987 Jan; 13(1):69-78. PubMed ID: 2436302
    [No Abstract]   [Full Text] [Related]  

  • 17. Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma.
    Schapira M; Scott CF; Colman RW
    J Clin Invest; 1982 Feb; 69(2):462-8. PubMed ID: 6173399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen.
    Scott CF; Schapira M; James HL; Cohen AB; Colman RW
    J Clin Invest; 1982 Apr; 69(4):844-52. PubMed ID: 7076850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A low molecular weight platelet inhibitor of factor XIa: purification, characterization, and possible role in blood coagulation.
    Cronlund AL; Walsh PN
    Biochemistry; 1992 Feb; 31(6):1685-94. PubMed ID: 1737024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.